DHR
Danaher Corporation · Healthcare · Diagnostics & Research
TECHBuyZACKSHold
R500#137 today
$214.06
+1.09% today · -4.48% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- DHR +1.09% on the last session vs SPY +0.74%: +0.3 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 60 big drops in the past 5 years, DHR typically gained 0.1% over the next day (median) and was higher 53% of the time; half the outcomes fell between -0.8% and +1.1%. An ordinary day: +0.0%. Among S&P 500 stocks after big drops, that ranks #221 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 21
Before the open · in 17 days
EPS estimate
$1.91
$1.83 to $1.99 · 20 analysts
Revenue estimate
$6.6B
$6.4B to $6.7B
Track record
7/8 beats
last 8 reports · moved ±5.1% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 21, 2026 BMO | 2Q2026 | $1.84 | $1.94 | +$0.10 (+5.3%) beat | $6.3B | -11.0% -11.8 vs SPY | -16.1% | -2.3% |
| Apr 21, 2026 BMO | 1Q2026 | $1.94 | $2.06 | +$0.12 (+6.5%) beat | $6.0B | -0.5% +0.2 vs SPY | +0.8% | -7.6% |
| Jan 28, 2026 BMO | 4Q2025 | $2.19 | $2.23 | +$0.04 (+2.0%) beat | $6.8B | -4.8% -4.8 vs SPY | -2.9% | -8.1% |
| Oct 21, 2025 BMO | 3Q2025 | $1.72 | $1.89 | +$0.17 (+9.8%) beat | $6.1B | +5.9% +5.9 vs SPY | +7.2% | +6.1% |
| Jul 22, 2025 BMO | $1.64 | $1.80 | +$0.16 (+9.8%) beat | — | +1.0% +1.0 vs SPY | -0.7% | +7.9% | |
| Apr 22, 2025 BMO | $1.64 | $1.88 | +$0.24 (+14.6%) beat | — | +3.8% +1.2 vs SPY | +7.2% | +5.9% | |
| Jan 29, 2025 BMO | $2.16 | $2.14 | −$0.02 (−0.9%) miss | — | -9.7% -9.3 vs SPY | -5.2% | -13.2% | |
| Oct 22, 2024 BMO | $1.57 | $1.71 | +$0.14 (+8.9%) beat | — | -4.0% -3.9 vs SPY | -3.0% | -10.3% | |
| Jul 23, 2024 BMO | $1.57 | $1.72 | +$0.15 (+9.6%) beat | — | +5.3% +5.5 vs SPY | +7.6% | +8.3% | |
| Apr 23, 2024 BMO | $1.71 | $1.92 | +$0.21 (+12.3%) beat | — | +7.2% +6.0 vs SPY | +7.9% | +4.5% | |
| Jan 30, 2024 BMO | $1.91 | $2.09 | +$0.18 (+9.4%) beat | — | +4.7% +4.8 vs SPY | +4.3% | +5.1% | |
| Oct 24, 2023 BMO | $1.88 | $2.02 | +$0.14 (+7.4%) beat | — | -3.5% -4.3 vs SPY | -5.0% | -9.3% | |
| Jul 25, 2023 BMO | $2.02 | $2.05 | +$0.03 (+1.5%) beat | — | -0.9% -1.1 vs SPY | -3.9% | -1.1% | |
| Apr 25, 2023 BMO | $2.26 | $2.36 | +$0.10 (+4.4%) beat | — | -8.8% -7.2 vs SPY | -3.6% | -5.0% | |
| Jan 24, 2023 BMO | $2.55 | $2.87 | +$0.32 (+12.5%) beat | — | -2.0% -1.9 vs SPY | -1.4% | -5.1% | |
| Oct 20, 2022 BMO | $2.25 | $2.56 | +$0.31 (+13.8%) beat | — | -5.7% -4.9 vs SPY | -6.3% | -1.6% | |
| Jul 21, 2022 BMO | $2.34 | $2.76 | +$0.42 (+17.9%) beat | — | +9.1% +8.1 vs SPY | +7.4% | +9.4% | |
| Apr 21, 2022 BMO | $2.66 | $2.76 | +$0.10 (+3.8%) beat | — | -0.8% +0.7 vs SPY | +1.1% | -10.0% | |
| Jan 27, 2022 BMO | $2.54 | $2.69 | +$0.15 (+5.9%) beat | — | +1.2% +1.7 vs SPY | +2.0% | +10.4% | |
| Oct 21, 2021 BMO | $2.15 | $2.39 | +$0.24 (+11.2%) beat | — | -1.3% -1.6 vs SPY | -0.1% | -3.0% | |
| Jul 22, 2021 BMO | $2.05 | $2.46 | +$0.41 (+20.0%) beat | — | — | — | — | |
| Apr 22, 2021 BMO | $1.77 | $2.52 | +$0.75 (+42.4%) beat | — | — | — | — | |
| Jan 28, 2021 BMO | $1.88 | $2.08 | +$0.20 (+10.6%) beat | — | — | — | — | |
| Oct 22, 2020 BMO | $1.36 | $1.72 | +$0.36 (+26.5%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $1.91 (20) | $1.83 – $1.99 | +1% | -7.5% | ▲0 ▼3 | $6.6B | +8% |
| Next quarter · Dec 31, 2026 | $2.58 (20) | $2.48 – $2.63 | +16% | +1.6% | ▲0 ▼1 | $7.6B | +11% |
| Current year · Dec 31, 2026 | $8.51 (25) | $8.45 – $8.55 | +9% | 0.0% | ▲1 ▼0 | $26.3B | +7% |
| Next year · Dec 31, 2027 | $9.30 (25) | $9.12 – $9.50 | +9% | +0.6% | ▲1 ▼1 | $28.5B | +8% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.